← All organizations

GlycoVaxyn

For profit

Also known as: GlycoVaxyn AG

Highest phase reached

Phase 1

First clinical trial

Feb 1, 2010

Last known activity

Jan 1, 2014

Acquired by GlaxoSmithKline on Jan 1, 2015

Timeline

2000s

  1. Jan 1, 2004

    GlycoVaxyn— Founded

2010s

  1. Jan 1, 2015

    GlaxoSmithKline— Acquired By

Drugs by trial phase (2 distinct, 2 trials)

Indications

Recent trials (3)

Details

Founded
Zurich, CH Jan 1, 2004
Last known activity
Jan 1, 2014